Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clin...(. The forward- lookingstatements should ...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Date:10/3/2007
. The forward- looking statements should be considered in light of these risks and uncertainties. We do not undertake, and expressly disclaim any obligation, to update or alter our statements whether as a result of new information, future events or otherwise, except as required by law.
'/>"/>
| SOURCE Rockwell Medical Technologies, Inc. Copyright©2007 PR Newswire. All rights reserved |
Related medicine technology :
1. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
2. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
3. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
4. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
5. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
6. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
7. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
8. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
9. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
10. Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with Electroporation DNA Delivery Technology and New Devices at Gene Therapy Meeting
11. World First Medical Treatment Announced by Researchers at Queen Mary University London and University of Leicester
Post Your Comments:
(Date:1/6/2009)...ificance of AHCC for maintaining a healthy immune ...-- A recently published study in Nutrition and Ca...dical University in Osaka, Japan has shown that AH...mune function by increasing the number of dendriti...stem responsible for presenting foreign substances...
(Date:1/6/2009)...Mass., Jan. 6 Cequent Pharmaceutic...s to deliver RNAi-based treatments to prevent and ...s recently completed a successful toxicology study...tk RNAi therapeutic targeting the primary oncogene...us polyposis). FAP is an inherited gastrointestina...
(Date:1/5/2009)...A, Md., Jan. 5 Micromet,...any developing novel, proprietary,antibodies for ...ne diseases,provides an outlook on key events an...ntends to provide an update on its research and de... -- April 12 to 16, 2009: Update on several pre...
(Date:12/29/2008)...d., Dec. 29 The winner ... Protection was announced today by Dr. Peter G. Go...rovement Institute. , , The winner of the annu...rson Cancer Center -- for its best practice " IN...m provides for 1) enhanced human subjects protecti...
Breaking Medicine Technology:Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 52008 Human Research Protection Award Recipients Announced 2URAC Announces Finalists for Best Practices in Health Care Consumer Empowerment and Protection Awards 29324 1URAC Announces Finalists for Best Practices in Health Care Consumer Empowerment and Protection Awards 29324 2URAC Announces Finalists for Best Practices in Health Care Consumer Empowerment and Protection Awards 29324 3URAC Announces Finalists for Best Practices in Health Care Consumer Empowerment and Protection Awards 29324 4Protect Your Family From The Silent Killer This Winter 29321 1Protect Your Family From The Silent Killer This Winter 29321 2Protect Your Family From The Silent Killer This Winter 29321 3Study improves recovery for mothers with depression 29317 1Medicare coding for maggots and maggot therapy 5791 1Medicare coding for maggots and maggot therapy 5791 2Medicare coding for maggots and maggot therapy 5791 3[0] Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells[2] Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference[2] Micromet Key Events for 2009[0] 2008 Human Research Protection Award Recipients Announced
...May 02, 2007 /PRNewswire-FirstCall/ --,Genelabs Te...on was,made today at the 20th International Confer...ngs, California, on a,non-nucleoside hepatitis C v...labs. , The oral presentation was given by Christo...istry at Genelabs, entitled,"GL59728: A Potent All...
... WIRE)--May 4, 2007 - Argos Therapeutics,today ann...essive,properties of soluble CD83 at the 7th Joint...ncisco, May 5-9. The presentations,will be made in...f,Western Ontario., "These data suggest that solub...lantation, and that it can also act,synergisticall...
Other Medicine Technology:Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 2Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 3Argos Therapeutics Presents Immunosuppression Data for Soluble CD83,at the American Society of Transplantation Congress 2007 2(Date:1/8/2009)...Jude study could shape new treatments for secondar...ire-USNewswire/ -- Scientists at St. Jude Children...ctive treatment for bacterial pneumonia following ...ycin and azithromycin, which kill bacteria by inhi... than a standard first-line treatment with the "be...
(Date:1/8/2009)...red bad cholesterol more effectively than Zocor ,...fter nearly a year of review, U.S. health official...use of the controversial cholesterol-lowering drug...on said there was no significant difference in car...rin and patients taking the drug Zocor. , But, ...
(Date:1/8/2009)... Jan. 8 Hanger Orthopedi...e that throughout the fourth quarter of 2008 it ac..., Rocky Mountain Orthotic-Prosthetics Center, Ries...rst Coast Orthotics & Prosthetics, and Orthope...ns add patient care centers to existing markets in...
(Date:1/8/2009)...CO, Jan. 8 Medivation, I...Hung, M.D., president and chief,executive officer...thcare,Conference on Wednesday, January 14, at 10...otel in San Francisco. , Dr. Hung will prov...velopment programs for Dimebon for Alzheimer,s and...
Breaking Medicine News(10 mins):Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 3Health News:FDA Backs Cholesterol Drug Vytorin 2Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2Health News:Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference 2[0] Study Finds More Effective Treatment for Pneumonia Following Influenza[0] FDA Backs Cholesterol Drug Vytorin[0] Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue[0] Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference
... expert, the way one sneezes or the sound that com...ualities of a person.// Patti A. Wood, an Atlanta-...r Benadryl, said a sneeze could offer a revealing ...ty, reported the online edition of ABC News. Wood...
... of the Irish Medical Organization (IMO) has expre...lection for Fine Gael// . Previously, Nora Owen, t... The ambitious contestant is seeking the nominatio... is positive about the success in the political pa...
...in grave consequences. People who are in their 60s...ise. This increases their physical function// and ...ead to a loss of functional independence in the co...r. Dennis T. Villareal from Washington University ...
... women aged 60 and younger have an increased susce...red to others. The results of the study are especi...sts of such patients when compared to heart attack... of the study have been published in the April 24 ...
Other Medicine News:Health News:Depression Accompanies Heart Attacks in Younger Women 2Vannas Capsulotomy scissors angled
Gills-Vannas straight capsulotomy flat handle scissors
Vannas angled capsulotomy round handle scissors
Solid blade speculum designed for both temporal and superior approach ocular surgery. Adjustable with thumb screw. Manufactured in titanium.
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |